Found 7 matching trials
An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer PHASE1 This phase I trial studies the side effects of 124I-hJAA-F11, and evaluates...
Show More Location
Multiple Locations
Learn More & Join Trial
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study PHASE2 This phase II trial studies how well giving testosterone at levels higher t...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) PHASE2 This study is an open-label, multicenter study designed to investigate the ...
Show More Status
Active Not Recruiting
Location
Macquarie University Hospital
Learn More & Join Trial
64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer PHASE1 This clinical trial tests the safety, side effects, best dose and feasibili...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors PHASE3 This is a randomized Phase II/late phase I de-escalation clinical trial wit...
Show More Location
Centre François BACLESSE
Learn More & Join Trial
PSMA PET Combined With MRI for the Detection of PCa PHASE3 This is an open label, longitudinal Phase 3 study of prostate specific memb...
Show More Location
University of California Los Angeles
Learn More & Join Trial
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer PHASE1 The main purpose of the study is to assess the safety and tolerability of A...
Show More Learn More & Join Trial